Patent Assignment
Reel/Frame 069483/0413
Assignment of Assignor's Interest
Recorded: 2024-12-04
Pages: 4
Assignors
MANCUSO, JOHN
Executed: 2021-06-18
BOS, MAXENCE
Executed: 2021-06-17
LY, VU LINH
Executed: 2021-06-16
Assignee
NUCHEM THERAPEUTICS, INC.
2350 COHEN ST. SUITE 201, VILLE SAINT-LAURENT, H4R 2N6, CANADA
Covered Property
(1)
Fused Imidazole Derivatives as Ahr Antagonists
Patent:
12,570,638 →
Application:
17/999,254 →
Publication:
US 2023/0331705
PCT:
PCT/US2021/033078 ↗
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 4, 2024
From: NUCHEM THERAPEUTICS, INC.
To: SENDA BIOSCIENCES, INC.
Reel/Frame 069483/0431 →
Assignment of Assignor's Interest
Dec 4, 2024
From: BARTOLOZZI, ALESSANDRA; PROUDFOOT, JOHN ROBERT; BRIGGS, TIMOTHY; BLOIS, ANNA
To: SENDA BIOSCIENCES, INC.
Reel/Frame 069483/0527 →
Assignment of Assignor's Interest
Dec 4, 2024
From: SENDA BIOSCIENCES, INC.
To: SAIL BIOMEDICINES, INC.
Reel/Frame 069483/0509 →